News

X-37 Announces $14.5 Million Series A

SOUTH SAN FRANCISCO, November 14, 2019 -- X-37, LLC, an artificial intelligence-enabled drug discovery company, announced today that it has closed a $14.5 million Series A financing. The funding round was led by DCVC Bio and was joined by Alpha Intelligence Capital and Hemi Ventures. The Series A funding will be used to expand the number of drug development programs at X-37 and to advance identifi...

Read More...